TrialBlood2026
PROs vs clinician-reported adverse events in a large clinical trial: findings from the phase 3 POLARIX study.
Carrie Thompson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
TrialBlood2026
Carrie Thompson et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.